Quantitative analysis of budralazine in human plasma and urine by gas chromatography-mass spectrometry.
Fujimaki
Y
Y
Drug Metabolism Research Center, Daiichi Seiyaku Co., Ltd., Tokyo, Japan.
Hakusui
H
H
Takegoshi
T
T
D000284:Administration, Oral; D000537:Aluminum Oxide; D000959:Antihypertensive Agents / Q000032:analysis* / Q000097:blood / Q000652:urine; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D006830:Hydralazine / Q000031:analogs & derivatives* / Q000032:analysis / Q000097:blood / Q000652:urine; D007202:Indicators and Reagents
D000959:Antihypertensive Agents; D007202:Indicators and Reagents; D006830:Hydralazine; D000537:Aluminum Oxide; C006153:budralazine